• SENSEX 74,412.18
    75.73 (+0.10%)
  • BANKNIFTY 56,292.45
    497.70 (+0.89%)
  • Kanohar Elect.
    885.65 786.95(%)
  • A B B
    7,161.10 7,923.35(%)
  • HDFC Bank
    713.25 682.00(%)
  • PB Fintech.
    1,719.30 1,334.20(%)
  • Glass Wall Syst.
    258.40 228.10(%)
  • Gland Pharma
    2,940.90 3,041.95(%)
  • IFCI
    80.95 107.45(%)
  • Entero Healthcar
    1,614.00 944.00(%)
  • JSW Infrast
    329.55 355.65(%)
  • Solar Industries
    18,600.00 11,641.10(%)
  • Syrma SGS Tech.
    1,658.40 1,676.15(%)
  • TVS Motor Co.
    4,162.80 4,484.70(%)
  • Nippon Life Ind.
    1,107.05 756.10(%)
  • Reliance Industries
    1,253.85 1,611.20(%)
  • Molbio Diagnosti
    1,274.05 925.80(%)
  • Pine Labs
    184.20 134.75(%)
  • Netweb Technol.
    4,486.60 2,820.80(%)
  • JSW Energy
    513.95 617.30(%)
  • Siemens Ener.Ind
    3,077.90 3,966.80(%)
  • Kaynes Tech
    3,563.00 7,705.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sanjivani Paranteral Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 6710.0
  • ISIN : INE860D01013
180.00 3 (1.52%)
  • As on 17 Sep 2026 (EOD)

  • Today’s Low

    176.30

  • Today’s High

    186.00

  • Open

    183.70

  • Perv Close

    177.30

  • 52W Low

    126.00

  • 52W High

    263.95

Key Indicators

  • P/E(TTM)

    29.51

  • Mar.Cap (₹Cr.)

    221.12

  • Div & Yield %

    0.00

  • Book Value(₹)

    39.39

  • Debt-Equity Ratio

    1.52

  • AGM Date

    16-Sep-2026

  • EPS

    6.10

  • P/E Ratio

    29.51

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    221.12

  • RONW (%)

    7.83

  • ROCE (%)

    9.77

Score Board

  • Equity (₹ in Cr.)

    12.28

  • BV (₹)

    39.40

  • Sales( ₹ in Cr.)

    64.76

  • NP (in Cr.)

    7.01

  • NP Var(%)

    -13.0

  • Div%

    0.0

  • CPS (₹)

    6.40

  • EPS (₹)

    5.70

  • Traded Value (₹ in Lakhs)

    221.12

  • 52 Week High

    263.95

  • 52 Week Low

    126.00

  • Price BSE

    180.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    221.12

  • P/C Ratio

    28.10

  • P/E Ratio

    31.50

  • Price Vs.BV

    5.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 64.76 70.10 54.41 41.47 30.61 25.10
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 64.76 70.10 54.41 41.47 30.61 25.10
Other Income 1.24 1.21 0.52 0.55 0.24 0.26
Stock Adjustments -0.28 -6.92 5.89 1.28 0.35 -0.67
Total Income 65.72 64.39 60.82 43.30 31.20 24.69
EXPENDITURE :            
Raw Materials 41.65 33.56 34.37 19.84 12.66 14.14
Power and Fuel Cost 1.11 1.37 1.14 1.10 0.98 0.78
Employee Cost 4.35 4.99 3.74 2.91 2.73 2.13
Other Manufacturing Expenses 1.78 2.67 3.24 2.19 1.98 1.08
Selling and Administration Expenses 5.90 9.97 9.45 5.32 7.22 2.91
Miscellaneous Expenses 0.31 0.25 0.12 -0.23 -0.33 1.25
Employee Benefit Expenses 4.35 4.99 3.74 2.91 2.73 2.13
Less: Preoperative Expenditure 0.00 0.00 0.00 -5.98 0.00 0.00
Total Expenses 55.09 52.81 52.06 37.11 25.24 22.30
Operating Profit 10.64 11.57 8.75 6.19 5.97 2.40
Interest 0.54 0.59 0.25 0.36 0.21 0.13
Gross Profit 10.10 10.98 8.50 5.83 5.76 2.27
Depreciation 0.86 0.62 0.93 0.89 0.88 0.86
Profit Before Tax 9.24 10.36 7.57 4.94 4.88 1.41
Current Tax 1.85 1.85 1.36 1.04 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.46 0.41 0.05 -0.61 0.03 -0.01
Reported Net Profit 6.92 8.10 6.17 4.51 4.85 1.42
Extraordinary Items -0.09 0.00 0.00 -0.01 0.00 0.00
Adjusted Net Profit 7.01 8.10 6.17 4.52 4.85 1.42
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -42.78 -50.89 -57.05 -61.56 -66.41 -67.83
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.61 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -36.48 -42.78 -50.89 -57.05 -61.56 -66.41
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 5.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.50 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.64 6.82 5.28 4.51 4.85 1.67
Earnings Per Share(Adj)-Unit Curr 5.64 6.82 5.28 4.51 4.85 1.67
Book Value 39.39 30.84 22.14 -3.07 -7.58 -52.83
Book Value(Adj)-Unit Curr 39.39 30.84 22.14 -3.07 -7.58 -52.83

Shareholding Pattern

  • Promoter Group

    31.56%

  • Public Share Holding

    68.44%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,877,527 31.56 3,877,527 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,877,527 31.56 3,877,527 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 669,843 5.45 669,843 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 669,843 5.45 669,843 2
2] Non Institution
Bodies Corporate 978,032 7.96 978,032 51
Clearing Members 531 0.00 531 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 104,164 0.85 103,664 87
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 325,481 2.65 325,481 158
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,358,234 27.34 3,358,234 32
Individuals holding nominal share capital up to Rs. 1 lakh 2,774,242 22.58 2,715,952 5,536
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 100 1
Others 0 0.00 0 0
Sub Total 7,736,930 62.98 7,678,140 5,876
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,284,300 100.00 12,225,510 5,880

Company Background

Sanjivani Paranteral LtdPharmaceuticals - Indian - Formulations

  • Sanjivani Paranteral Ltd
  • BSE Code : 6710.0
  • ISIN : INE860D01013

  • Incorporation Year

    1994

  • Registered Office

    205 P N Khotari Indl Estate
    LBS Marg Bhandup (West), Mumbai,
    Maharashtra-400078

  • Telephone

    91-22-67290900

  • FAX

    91-22-67290930

  • Chairman

    Ashwin Khemka

  • Managing Director

  • Company Secretary

    Ravikumar Bogham

  • Auditor

    R B Gohil & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Sanjivani Paranteral Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sanjiv.Parant. 180.00 66.00 64.76 29.51 10.77
Abbott India 26,118.60 7,217.19 6,929.05 34.37 43.78
Astrazeneca Phar 6,710.80 2,304.07 2,275.58 98.91 27.86
Glaxosmi. Pharma 2,853.85 3,932.76 3,790.20 45.59 58.17
Novartis India 1,996.85 393.10 354.33 50.43 15.94
Cipla 1,359.75 20,102.60 18,979.95 35.74 13.88
Bliss GVS Pharma 679.90 773.53 729.81 63.19 12.51
Amrutanjan Healt 489.60 520.13 502.55 26.22 24.16
Fermenta Biotec. 468.85 474.15 450.25 21.89 18.77
Guj. Themis Bio. 412.35 168.25 165.82 110.25 18.05
Ambalal Sarabhai 39.36 19.52 3.94 72.89 6.77